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Abstract
Endometriosis generally occurs in the ovary. Intestinal endometriosis is rare. About 1 % of all endometriosis cases
become malignant. Malignant transformation of small intestinal endometriosis is very rare. A 55-year-old woman
who underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy and omentectomy for
endometriosis 7 years ago presented to her primary care doctor with melena. A tumor was detected in the right
lower abdomen by ultrasonography. The doctor referred her to our hospital. Computed tomography demonstrated
a lobulated tumor ventral to the right common iliac vessels. Magnetic resonance imaging demonstrated that the
tumor had heterogeneous intensity on T2-weighted images. Several small cysts with high intensity were observed
caudal to the tumor on T2-weighted images. We performed partial small intestinal resection for the lesion. The
tumor was diagnosed as endometrioid adenocarcinoma of the small intestine. She has been relapse-free for 5 years
after surgery. Only three cases of malignant transformation of small intestinal endometriosis have been reported
previously. It is very rare for long-term survival to be obtained with surgery alone, as in our case. This case report
highlights the imaging findings for malignant transformation of intestinal endometriosis.
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Background
Endometriosis generally occurs in the ovary. It rarely
involves the intestinal tract. Almost all reported cases
of intestinal endometriosis involve the sigmoid colon
and rectum [1]. There have been relatively few re-
ports of endometriosis in the small intestine. Malig-
nant transformation occurs in approximately 1 % of
all endometriosis cases [2]. We report a very rare
case of endometrioid adenocarcinoma, which is endo-
metriosis with malignant transformation, in the small
intestine.
Case presentation
A 55-year-old woman presented to her primary care
doctor with melena. A tumor in the right lower abdo-
men was detected by ultrasonography. The doctor re-
ferred her to our hospital for further examination and
treatment. She underwent total abdominal hysterectomy
and bilateral salpingo-oophorectomy and omentectomy
for endometriosis 7 years ago.
On physical examination, a tumor was slightly palpable
in the right lower abdomen. Computed tomography of the
abdomen demonstrated a 6.5 × 4 cm lobulated tumor ven-
tral to the right common iliac vessels. Enlarged lymph
nodes were observed in the area of the ileocolic artery.
She also underwent a contrast-enhanced magnetic
resonance (MR) imaging examination. The tumor had
intermediate signal intensity, similar to that of
muscle, on T1-weighted images and heterogeneous in-
tensity on T2-weighted images. On contrast-enhanced
MR images with gadolinium, the mass was enhanced
heterogeneously. Several small cysts that were hypointense
on T1-weighted images and hyperintense on T2-weighted
images were observed caudal to the tumor (Fig. 1).
Blood tests revealed anemia, with a hemoglobin con-
centration of 8.5 g/dL. Serum concentrations of carci-
noembryonic antigen and carbohydrate antigen 125
were 1.7 ng/mL and 14 U/mL, respectively. Endoscopic
examination did not detect any tumors or sites of bleed-
ing in the colon.
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We suspected primary small intestinal cancer, a retro-
peritoneal tumor with invasion to the small bowel, or
endometriosis with malignant transformation. Surgery
was performed. Intraoperatively, we observed that the
tumor was located ventral to the right common iliac ves-
sels. Because the tumor invaded the ileum 35 cm prox-
imal to the end of the ileum, we performed partial small
intestinal resection (Fig. 2).
Histologically, the tumor penetrated to the mucosa of
the small intestine. The tumor consisted of two types of
stromal tissue (endometriosis type and ovarian type) and
atypical endometrioid glandular epithelium. The atypical
cells were immunopositive for cytokeratin 7 but were
negative for cytokeratin 20. The histopathological diag-
nosis was endometrioid adenocarcinoma (Fig. 3). The
stromal tissues in the wall of the small intestine sur-
rounded the adenocarcinoma component. The endome-
trioid adenocarcinoma was localized in the intestinal
wall. Small intestinal endometriosis was considered the
site of malignant transformation. There was no lymph
node metastasis. Postoperative chemotherapy was not
performed. She has been relapse-free for 5 years after
surgery.
Discussion
The clinical course of this patient illustrates two import-
ant clinical points. Malignant transformation of endo-
metriosis can occur in the small intestine. MR imaging
is useful in the diagnostic evaluation of malignant endo-
metriosis in the small intestine.
First, malignant transformation of endometriosis can
occur in the small intestine. The ovary is the site of
80 % of all endometriosis cases. Abdominal endomet-
riosis accounts for 5.3 to 12 % of endometriosis [3].
Intestinal endometriosis mainly occurs in the sigmoid
colon and rectum, and these two sites account for
77 % of abdominal endometriosis [1]. About 1 % of
all endometriosis cases become malignant [2]. Only
three cases of malignant endometriosis in the small
intestine have been reported (Table 1) [4–6]. It is very
Fig. 1 MR imaging. a T2-weighted imaging. A lobulated tumor was observed ventral to the right common iliac artery. The tumor had
heterogeneous intensity. b, c T2-weighted imaging. Some high-intensity cystic lesions (arrow) were detected around the tumor. d T1-weighted
imaging. The mass had heterogeneous enhancement (arrowheads indicate the outline of the tumor)
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rare for long-term survival to be obtained with sur-
gery alone, as in our case.
Second, MR imaging is useful for diagnosing malig-
nant endometriosis in the small intestine. Endometriosis
in the rectum is often assessed with MR imaging, with
very high diagnostic accuracy. Compared to rectal endo-
metriosis, the diagnostic accuracy of intestinal endomet-
riosis with MR imaging is lower [7]. Endometriosis in
the acute phase is characterized by high signal intensity
on both T1- and T2-weighted images, which is suggest-
ive of the presence of subacute hemorrhage. During the
chronic phase, shading, which is defined as a centrally or
peripherally located low-intensity area in a hyperintense
cyst, can be observed on T2-weighted images [8]. If solid
nodules exist in a cyst, there is a possibility of malignant
transformation. Contrast-enhanced MR imaging with
gadolinium is considered when solid components of
endometriosis are suspected to be malignant. In the
study of mural nodules within cysts, malignant endomet-
riosis is characterized by the lack of shading on T2-
weighted images, high signal intensity on diffusion-
weighted images, and heterogeneous enhancement on
MR images with contrast [9]. In our case, the tumor had
surrounding small cysts with low intensity on T1-
weighted images, heterogeneous intensity on T2-
weighted images, and heterogeneous enhancement on
T1-weighted images with contrast. Small cysts are con-
sidered to reflect endometriosis, while heterogeneous
Fig. 3 Microscopic findings. Sixteen tumor cells had nuclear atypia and irregular glandular structures (hematoxylin-eosin 17 stain, ×40)
Fig. 2 Macroscopic findings. The tumor (arrows) invaded the intestinal mucosa
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enhancement on T1-weighted images reflects malignant
transformation. In patients with a history of endometri-
osis, when a tumor with cysts is detected, we need to
consider the possibility of malignant transformation aris-
ing from intestinal endometriosis. Contrast-enhanced
MR imaging may be useful in the diagnostic evaluation
of malignant endometriosis in the small intestine.
Surgical resection is the first-choice treatment for
malignant endometriosis. Lymph node metastasis and
peritoneal dissemination have been reported to be poor
prognostic factors [10, 11]. Patients with either factor
may benefit from postoperative chemotherapy. In the
case of endometrioid adenocarcinoma of the ovary, the
recommended postoperative chemotherapy regimen is
carboplatin plus paclitaxel [12, 13]. If the tumor is local-
ized and well differentiated and there is no lymph node
metastasis, postoperative chemotherapy may be omitted
in ovarian cancer. However, the evidence base for post-
operative chemotherapy to treat intestinal malignant
endometriosis has not been fully established because of
the small number of cases. In the present case, endome-
trioid adenocarcinoma was localized to the intestinal
wall, resection margins were negative, and complete
resection was performed. There was no lymph node
metastasis and histological examination showed that the
tumor was well differentiated. We consulted with the
patient and decided not to perform postoperative
chemotherapy.
Conclusions
Malignant endometriosis can arise in the small intes-
tine and MR imaging is useful for diagnosing endo-
metriosis with malignant transformation. Although
there is a need to accumulate more cases, we
propose that contrast-enhanced MR imaging is useful
for detecting malignant transformation of intestinal
endometriosis.
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